What's new? Log in Free sign up

Neurometrix (NURO) News and press releases

Company Profile

News

From Benzinga Pro

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 148 companies set new 52-week lows.

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

NeuroMetrix Q1 EPS $(0.20) Down From $(0.14) YoY, Sales $1.70M Down From $2.30M YoY

NeuroMetrix (NASDAQ:NURO) reported quarterly losses of $(0.20) per share. This is a 42.86 percent decrease over losses of $(0.14) per share from the same period last year. The company reported $1.70 million in sales

NeuroMetrix To Exhibit Quell Fibromyalgia And Present New Clinical Data At The American Academy Of Pain Medicine 2023 Annual Meeting

Biotech, News, FDA, Events, General

NeuroMetrix, Inc. (NASDAQ:NURO) will exhibit Quell Fibromyalgia at the American Academy of Pain Medicine 39th Annual Meeting on March 23 - 26 in Ft. Lauderdale, FL. In addition, two scientific posters reporting new

Press releases

From Benzinga Pro

Quell® Demonstrates Encouraging Clinical Trial Results in Chemotherapy Induced Peripheral Neuropathy (CIPN)

Health Care, Press Releases

WOBURN, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) noted publication of an abstract describing partial results from a NIH-funded, multi-site randomized controlled trial of Quell titled

NeuroMetrix Reports Q1 2023 Financial Results

Earnings, Press Releases

WOBURN, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today reported financial and business highlights for the quarter ended March 31, 2023. The Company's mission is to reduce the impact of

NeuroMetrix, Inc. Announces Date for First Quarter 2023 Financial Results Conference Call

WOBURN, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2023 first quarter financial results before the opening of the market on May 3, 2023. The

NeuroMetrix to Exhibit Quell® Fibromyalgia and Present New Clinical Data at the American Academy of Pain Medicine 2023 Annual Meeting

News, Press Releases, General

WOBURN, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) will exhibit Quell Fibromyalgia at the American Academy of Pain Medicine 39th Annual Meeting on March 23 - 26 in Ft. Lauderdale, FL. In

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.